No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BRCC241220P2000
- 0.05
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume20 Open Interest2.00Strike Price0.00Turnover0.00%IV33.45%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma58.60Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Which Subsectors to Own and Which to Avoid – Wolfe Research
BRC-002 Receives Orphan Drug Designation From FDA for Complex Regional Pain Syndrome
Analysts Have Been Trimming Their BRC Inc. (NYSE:BRCC) Price Target After Its Latest Report
Roth MKM Reiterates Neutral on BRC, Lowers Price Target to $3.5
BRC Analyst Ratings
Express News | BRC Inc : Truist Securities Cuts Target Price to $4 From $5